Literature DB >> 23045467

Can physiology zap therapeutic sweet spots in hypertension?

Michael J Joyner.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23045467      PMCID： PMC3499672          DOI： 10.1161/HYPERTENSIONAHA.112.202754

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  14 in total

1.  Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial.

Authors:  Murray D Esler; Henry Krum; Paul A Sobotka; Markus P Schlaich; Roland E Schmieder; Michael Böhm
Journal:  Lancet       Date:  2010-11-17       Impact factor: 79.321

2.  Why physiology matters in medicine.

Authors:  Michael J Joyner
Journal:  Physiology (Bethesda)       Date:  2011-04

3.  Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg.

Authors: 
Journal:  JAMA       Date:  1967-12-11       Impact factor: 56.272

4.  Reengineering the national clinical and translational research enterprise: the strategic plan of the National Clinical and Translational Science Awards Consortium.

Authors:  Steven E Reis; Lars Berglund; Gordon R Bernard; Robert M Califf; Garret A Fitzgerald; Peter C Johnson
Journal:  Acad Med       Date:  2010-03       Impact factor: 6.893

Review 5.  Sympathetic nervous system and blood pressure in humans: individualized patterns of regulation and their implications.

Authors:  Michael J Joyner; Nisha Charkoudian; B Gunnar Wallin
Journal:  Hypertension       Date:  2010-05-24       Impact factor: 10.190

Review 6.  Confusion about the appropriate use of erythropoiesis-stimulating agents in patients undergoing maintenance dialysis.

Authors:  Wolfgang C Winkelmayer
Journal:  Semin Dial       Date:  2010 Sep-Oct       Impact factor: 3.455

Review 7.  Translational medicine: the antihypertensive effect of renal denervation.

Authors:  Gerald F DiBona; Murray Esler
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-12-02       Impact factor: 3.619

8.  Catheter-based renal nerve ablation and centrally generated sympathetic activity in difficult-to-control hypertensive patients: prospective case series.

Authors:  Julia Brinkmann; Karsten Heusser; Bernhard M Schmidt; Jan Menne; Gunnar Klein; Johann Bauersachs; Hermann Haller; Fred C Sweep; Andre Diedrich; Jens Jordan; Jens Tank
Journal:  Hypertension       Date:  2012-10-08       Impact factor: 10.190

9.  Improvements in blood pressure, glucose metabolism, and lipoprotein lipids after aerobic exercise plus weight loss in obese, hypertensive middle-aged men.

Authors:  D R Dengel; J M Hagberg; R E Pratley; E M Rogus; A P Goldberg
Journal:  Metabolism       Date:  1998-09       Impact factor: 8.694

10.  Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

Authors:  David A Calhoun; Daniel Jones; Stephen Textor; David C Goff; Timothy P Murphy; Robert D Toto; Anthony White; William C Cushman; William White; Domenic Sica; Keith Ferdinand; Thomas D Giles; Bonita Falkner; Robert M Carey
Journal:  Hypertension       Date:  2008-04-07       Impact factor: 10.190
View more
  1 in total

1.  Should we be 'doping' the peripheral chemoreceptors?

Authors:  Jacqueline K Limberg; Michael J Joyner
Journal:  J Physiol       Date:  2014-03-15       Impact factor: 5.182
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.